Background: As the body’s first line of defense against environmental stressors, the skin is highly susceptible to UVB-induced damage, which triggers inflammation and impairs barrier function. This study investigates the protective effects of safflower seed oil (SSO) and fermented Artemisia annua oil (FAAO) against UVB-induced skin injury. Methods: The protective effects of SSO and FAO against UVB irradiation was first tested in HaCaT keratinocyte. Subsequently, a UVB-irradiated SKH-1 mouse model was established to evaluate these two oils. RNA-seq analysis was employed to investigate the potential molecular mechanisms by which SSO and FAO repair the skin barrier. Results: In vitro experiments demonstrated that SSO (0.25%) and FAAO (0.1%) significantly enhanced HaCaT keratinocyte viability following UVB exposure while selectively modulating pro-inflammatory cytokine production. In a UVB-irradiated SKH-1 mouse model, standalone SSO or FAAO treatment partially ameliorated epidermal hyperplasia and restored UV-reduced collagen content, while the 1:1 SSO/FAAO combination exhibited superior efficacy in restoring skin architecture, reducing erythema and edema, and suppressing immune cell infiltration. Transcriptomic profiling revealed that the combined treatment promoted structural repair by attenuating inflammatory responses and preserving extracellular matrix homeostasis. Conclusions: Together, these findings underscore the potential of SSO/FAAO as a multifunctional botanical intervention for mitigating UVB-induced cutaneous damage.
Objective: Ablative fractional laser (AFL) therapy impairs epidermal barrier integrity through the disruption of stratum corneum lipids and keratinocyte differentiation, resulting in increased transepidermal water loss (TEWL) and delayed functional recovery. This study aims to develop a more effective barrier repair strategy and evaluate the efficacy of topical safflower seed oil (SSO) in promoting post-AFL barrier restoration. Methods: An optimized murine AFL model (20 W, 0.5 ms pulse delay, and 0.7 mm spot spacing) was established to investigate skin repair mechanisms. SSO composition was characterized by gas chromatography–mass spectrometry (GC-MS). Epidermal repair was assessed using confocal laser scanning microscopy, while Oil Red O staining and immunofluorescence were employed to evaluate lipid formation and the expression of lipid synthesis-related genes, respectively. Results: GC-MS analysis identified SSO as a rich natural source of linoleic acid (69.1%) and oleic acid (18.7%). Over the 7-day period of AFL exposure alone, TEWL rose by 4–6 fold in mouse skin, accompanied by a near-complete loss of epidermal lipid synthesis. However, upon SSO administration, a marked reduction in TEWL was observed from day 1, and epidermal lipid synthesis recovered by day 7. Moreover, SSO treatment significantly upregulated epidermal PPARγ expression in AFL-injured skin. Pharmacological inhibition of PPARγ (T0070907) largely abrogated the lipid synthesis and barrier repair effects of SSO, while PPARα antagonism (GW6471) showed no obvious interference with SSO’s therapeutic efficacy, suggesting a potential association between PPARγ signaling modulation and SSO-mediated skin barrier restoration. Conclusions: These findings suggest that SSO is a promising natural agent for post-AFL skin care, which improves AFL-impaired skin barrier function by remodeling lipid metabolism, at least in part through PPARγ signaling, and warrants further preclinical and clinical investigation.